The Turkish biotech start-up focuses on developing safe and sustainable solutions for commercializing biotech-based systems. They offer a wide range of R&D services, products, and partnerships in the field of biotechnology and genetic engineering. Their platform creates cells of genetic circuits and combined parts of various viral deoxyribonucleic acid, which enables pharma companies to overcome challenging biological issues like cancer. GEEN Biotech develops tailor-made cell strains for every project, assigning a professional working team and scientific advisory board. They offer services such as order-based recombinant protein production and non-GMO industrial cell strain development. Currently, the company carries out projects in four main fields: pharma, biospecifity agents, plant biotechnology, and high-performance biomaterials, with projects in new fields in the pipeline.